Table 2.
Lesion Characteristics | Number of Patients | Percent (95%CI) |
---|---|---|
Lesion location | ||
RUL | 92 | 61% (53%, 69%) |
RML | 74 | 49% (41%, 57%) |
RLL | 109 | 72% (64%, 79%) |
LUL | 92 | 61% (53%, 69%) |
LLL | 85 | 56% (48%, 64%) |
Peripheral | 66 | 44% (36%, 52%) |
Central | 5 | 3% (1%, 8%) |
Both Peripheral and Central | 79 | 52% (44%, 60%) |
No. of lesions | ||
Solitary | 31 | 21% (14%, 28%) |
1–5 lesions | 31 | 21% (14%, 28%) |
6–10 lesions | 13 | 9% (5%, 14%) |
>10 lesions | 14 | 9% (5%, 15%) |
Diffuse | 62 | 41% (33%, 49%) |
Margin of dominant leison | ||
Smooth | 16 | 11% (6%, 17%) |
Lobular | 21 | 14% (9%, 20%) |
Spiculated | 35 | 23% (17%, 31%) |
Ill-Defined | 78 | 52% (43%, 60%) |
Lesion Consistency | ||
Solid | 67 | 44% (36%, 53%) |
Internal GGO | 80 | 53% (45%, 61%) |
Air Bronchograms | 40 | 26% (20%, 34%) |
Additional lesion Characteristics | ||
Surrounding GGO | 33 | 22% (16%, 29%) |
Cavitation | 9 | 6% (3%, 11%) |
Necrosis | 1 | 1% (0%, 4%) |
Adjacent Bronchiectasis | 4 | 3% (1%, 7%) |
Ancillary features | ||
Lymphadenopathy | 65 | 43% (35%, 51%) |
Effusion | 68 | 45% (37%, 53%) |
Associated Pathology Findings | ||
None | 99 | 66% (57%, 73%) |
Granulomas | 13 | 9% (5%, 14%) |
Bacteria/Organism | 7 | 5% (2%, 9%) |
Reactive Type II Pneumocytes | 8 | 5% (2%, 10%) |
Chronic Inflammation | 9 | 6% (3%, 11%) |
Acute Inflammation | 7 | 5% (2%, 9%) |
Atypical Adenomatous Hyperplasia | 1 | 1% (0%, 4%) |